<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01598272</url>
  </required_header>
  <id_info>
    <org_study_id>11-PHX-03-NU-01</org_study_id>
    <nct_id>NCT01598272</nct_id>
  </id_info>
  <brief_title>Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women</brief_title>
  <acronym>Pharmanex</acronym>
  <official_title>A Phase IV, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Single-Center Study on the Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pharmanex</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aspen Clinical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pharmanex</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine the effects of 8 week Investigational Supplement on cellular detoxification and
      gene expression profiles
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine effects of investigational supplement on gene expression profiles.</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>Gene Expression Panel (microarray PBMCs), Inflammatory Panel, Oxidative stress Markers-including glutathione panel and F2 isoprostane, Anti-oxidant panel, and Lipid Panel</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Establish a safety profile of investigational supplement</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>Measure number of participants with adverse events. Fasted Safety Labs (chemistry, hematology, Coagulation)compared to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine effects of investigational supplement on markers of inflammation</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine effects of investigational supplement on composite cognitive index</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine changes in scoring on HADS assessment (Hospital Anxiety &amp; Depression Scale)</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>Questionnaire: Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine changes in Quality of Life</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>SF-36 (Quality of Life Assessment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine changes in sleep patterns and quality</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>Sleep measurement scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine changes to overall health</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>Abbreviated Physical Exam</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine changes to biological age scanning (Digital Pulse Wave Analyzer (DPA)</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>Digital Pulse Wave Analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine changes in Biophotonic Scanner Scores</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>Measure antioxidants in the palm of the skin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine changes in skin advanced glycation endproducts (AGE) levels</measure>
    <time_frame>Day 0, Day 28, Day 56</time_frame>
    <description>AGE Reader</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Anti Aging</condition>
  <arm_group>
    <arm_group_label>Vitality product AM + Vitality product PM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary Supplement:
Proprietary blend of ginseng, cordyceps, and pomegranate + proprietary blend of broccoli seed, red orange, and grape seed taken twice a day for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dietary Supplement: Placebo Placebo taken twice a day for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitality product AM + Vitality product PM</intervention_name>
    <description>Vitality AM: Tak 6 capsules daily for 56 days Vitality PM: Take 2 capsules daily for 56 days</description>
    <arm_group_label>Vitality product AM + Vitality product PM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo AM: Take 6 capsules daily for 56 days Placebo PM: Take 2 capsules daily for 56 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Females aged 35-73 years

          2. Signed informed consent

          3. BMI between 23 and 35 kg/m2

          4. A resting normotensive blood pressure is defined as a systolic blood pressure between
             90-145 mmHg and a diastolic blood pressure of 50 90 mmHg

          5. BioPhotonic scanner score below 30,000

          6. Use of effective method of contraception by females of childbearing [potential and
             agreement to continue to practice an acceptable method of contraception for the
             duration of their participation in the study]. Acceptable methods of contraception
             include oral, injectable, or implantable contraceptives; intrauterine devices,
             diaphragm plus spermicide; or any double barrier method. Women who have had a
             hysterectomy or tubal ligation at least 6 months prior to Visit 1 or who have been
             post-menopausal for at least 1 year prior to Visit 1 are not considered to be of
             childbearing potential.

          7. Ability to speak and understand English.

          8. Willing to consume one high-fat high carbohydrate meal at the last visit consisting of
             1 McDonald's egg Mcmuffin with cheese (no meat), 1 Sausage McMuffin with cheese (no
             egg), 2 hashbrowns, 1 12 oz Coke Cola or Sprite.

          9. Willing to not exercise the morning of your last visit

        Exclusion Criteria:

          1. Self-reported chronic condition that may affect subject safety (e.g., diabetes,
             cardiovascular disease) or significantly impact product effectiveness (e.g., chronic
             fatigue)

          2. Pregnancy/suspected pregnancy, breastfeeding or planning to become pregnant during the
             course of the study.

          3. Antihypertensive medication use.

          4. Allergies to any ingredients contained in the Investigational Product.

          5. Consumption of more than 600 mg of caffeine from all sources per day (equivalent to 24
             oz. caffeinated coffee, 96 oz. of soda, 60 oz. of tea, 60 oz. energy drinks , or a
             combination thereof).

          6. Consumption of herbal supplement known to affect energy levels (e.g., ginseng,
             cordyceps, licorice, Lycium, pomegranate, etc.).

          7. Consumption of any of the supplements included in the formulas (Cordyceps sinensis,
             Panax Ginseng extract, pomegranate extract, red orange complex, grape seed extract or
             broccoli seed extract).

          8. Known iron deficiency anemia.

          9. Treatment for insomnia or depression within 30-days prior to the screening visit.

         10. Recently started taking medication known to effect energy (e.g., thyroid medication).
             If taking medication (e.g., thyroid medication), must be stable for at least four
             months.

         11. Tobacco (e.g. cigarettes, chewing tobacco, pipe, nicotine patches) use within 30-days
             prior to the screening visit.

         12. Planned surgical procedure during the course of the study.

         13. Currently participating in another study or have done so within 30 days prior to the
             screening visit or is likely to enroll in another clinical or nutritional study.

         14. Any laboratory value that the investigator deems clinically significant.

         15. Currently participating in a weight loss program or planning to go on a weight loss
             diet during the course of the study.

         16. Allergies to egg or dairy products, Vegetarian or unwilling to consuming sausage.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>73 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Harris, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aspen Clinical Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aspen Clinical Research</name>
      <address>
        <city>Orem</city>
        <state>Utah</state>
        <zip>84058</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2012</study_first_submitted>
  <study_first_submitted_qc>May 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2012</study_first_posted>
  <last_update_submitted>December 10, 2014</last_update_submitted>
  <last_update_submitted_qc>December 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ginseng</keyword>
  <keyword>Cordyceps</keyword>
  <keyword>Pomegranate</keyword>
  <keyword>Red Orange</keyword>
  <keyword>Grape Seed</keyword>
  <keyword>Broccoli Seed</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

